Remove Article Remove Marketing Remove Organic Chemistry
article thumbnail

Antibody Drug Conjugates: windows of opportunity

Drug Target Review

In this article, Petra Dieterich, Ian Glassford, and Jeff Mocny, Scientific Leaders at Abzena discuss real-world data that is challenging traditional scientific thinking on the ADC therapeutic window. The global ADC market is expected to continue this steep upward trajectory and is anticipated to exceed $16 Billion by 2026.

article thumbnail

Women in Stem with Dr Emily Leproust

Drug Target Review

I started my journey in chemistry – first as an undergraduate and then in my PhD programme at the University of Houston, where I focused on organic chemistry and nucleic acids chemistry. Can you tell us about your journey in the field of STEM and the challenges you encountered along the way?

DNA 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Marquis Who’s Who Honors David R. Elmaleh, PhD, with Inclusion in Who’s Who in the World

The Pharma Data

A graduate of the Hebrew University of Jerusalem, he earned a Bachelor of Science in chemistry and physics and a Master of Science in physical organic chemistry before completing a Doctor of Philosophy in 1971. Elmaleh has contributed to more than 130 book chapters, scientific papers, and professional journal articles.

article thumbnail

Article Periodic Thank You USGS estimates at least 45% of U.S. tap water contains PFAS

Agency IQ

These carbon-fluorine bonds are some of the strongest in organic chemistry, meaning that most PFAS readily persist in the environment.

article thumbnail

Marquis Who’s Who Honors James D. McChesney, PhD, with Inclusion in Who’s Who in the World

The Pharma Data

He continued his education at Indiana University, where he completed a Master of Arts in botany in 1964, and a Doctor of Philosophy in organic chemistry in 1965. He attributes his success to good fortune and hard work, and hopes to see some of his patented compounds gain approval and reach market readiness in the coming years.

article thumbnail

How to Get Drugs Into the Brain

Drug Hunter

This article will discuss various molecular design strategies for reducing BBB efflux and increasing passive permeability. Dennis obtained his PhD in Organic Chemistry from the University of Göttingen in 2013 specializing in carbohydrate chemistry and transition-metal catalysis.

Drugs 206
article thumbnail

Empowering women in STEM: Navigating CMC regulatory affairs

Drug Target Review

Dr Lopa Bakrania brings over 18 years of experience in pharmaceutical process chemistry and CMC regulatory affairs. As Executive Director of CMC Regulatory Affairs at Biohaven , she leads efforts to develop innovative therapies from the clinic to market approval. When I joined, I was one of only five women on a team of 150 men.

Science 59